Study of Pneumococcal Carriage in RSV Bronchiolitis in Infants Aged 6 to 18 Months
NCT06722716 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2025-05-15
Summary
The relationship between RSV (human respiratory syncytial virus) infections and invasive infections or pneumonia caused by Streptococcus pneumoniae has been observed epidemiologically for several years. Few fundamental data exist to support the epidemiological relationship. This study will investigate the proportion of pneumococcal carriage in RSV-infected infants and noninfected infants (proportion, serotype profile).
Conditions
- Bronchiolitis
Interventions
- OTHER
-
Swab collection
Nasopharyngeal swab
Sponsors & Collaborators
-
National Pneumococcal Reference Center
collaborator UNKNOWN -
Infectious Diseases Models for Innovative Therapies
collaborator UNKNOWN -
Assistance Publique - Hôpitaux de Paris
lead OTHER
Eligibility
- Min Age
- 6 Months
- Max Age
- 18 Months
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-10-31
- Primary Completion
- 2026-02-28
- Completion
- 2026-02-28
Countries
- France
Study Locations
More Related Trials
-
Immunogenicity of PCV-7 Vaccine in VLBW Infants
NCT00273325 ·Status: COMPLETED
-
PCV7 in the Prevention of Nasopharyngeal Carriage of Vaccine Serotype (VT) Streptococcus Pneumoniae
NCT02133469 ·Status: COMPLETED ·Phase: NA
-
Evaluating Vaccine Responses in Healthy Infants Receiving Their Routine Primary Immunisation According to the Accelerated United Kingdom Schedule at 2, 3 and 4 Months
NCT01425372 ·Status: COMPLETED
-
Study Evaluating the Impact of a 13-valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization
NCT00508742 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety Study of 15-Valent Pneumococcal Conjugate Vaccine in 2-month-old and 3-month-old Healthy Volunteers
NCT04357522 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Study Evaluating 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Healthy Children Aged 15 Months to 17 Years
NCT00761631 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine.
NCT00370396 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (PCV13i) in Healthy Infants Aged 2 Months (Minimum 6 Weeks)
NCT07017777 ·Status: RECRUITING ·Phase: PHASE3
-
Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants
NCT04398706 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Safety, Tolerability and Immunogenicity of ASP3772, a Pneumococcal Vaccine, in Toddlers 12 to 15 Months of Age in Comparison to an Active Comparator
NCT04525599 ·Status: COMPLETED ·Phase: PHASE1
-
Immunogenicity and Safety Study of the 13-valent Pneumococcal Polysaccharide Conjugate Vaccine in 2-71 Months Old Healthy Infants and Toddlers (the Youngest Could be 6 Weeks Old)
NCT02736240 ·Status: COMPLETED ·Phase: PHASE3
-
Surveillance of Invasive Pneumococcal Infections in Adults (Excluding Meningitis)
NCT03983616 ·Status: UNKNOWN
-
Study Evaluating Antibody Response Of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) 24 Months After Toddler Dose.
NCT01026038 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating 13-valent Pneumococcal Conjugate Vaccine In Healthy Infants
NCT00444457 ·Status: COMPLETED ·Phase: PHASE3
-
Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy Adults
NCT01444352 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Trial of 13-Valent Pneumococcal Conjugate Vaccine
NCT06617715 ·Status: RECRUITING ·Phase: PHASE3
-
Carriage to Assess Protection of New Pneumococcal Vaccines - PCV15
NCT06731374 ·Status: RECRUITING ·Phase: PHASE4
-
Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants in Brazil
NCT00676091 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants
NCT00475033 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese Infants and Young Children
NCT03574389 ·Status: COMPLETED ·Phase: PHASE3
-
Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age
NCT07348692 ·Status: RECRUITING ·Phase: PHASE3
-
A COHORT STUDY TO EVALUATE IMMUNOGENICITY FOR CHINESE CHILDREN AT THE TIME OF CLINICAL PNEUMONIA DIAGNOSIS
NCT05372575 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine
NCT00370227 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating 13-valent Pneumococcal Conjugate Vaccine Catch-Up Regimens in Older Infants and Children
NCT00452452 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Two Lots of V114 in Healthy Infants (V114-008)
NCT02987972 ·Status: COMPLETED ·Phase: PHASE2